Uy GL, Newell LF, Lin TL, et al. Transplant outcomes after CPX-351 vs 7 + 3 in older adults with newly diagnosed high-risk and/or secondary AML. Blood Adv. 2022;6(17):4989-4993
- PMID: 37318935
- PMCID: PMC10333738
- DOI: 10.1182/bloodadvances.2023010005
Uy GL, Newell LF, Lin TL, et al. Transplant outcomes after CPX-351 vs 7 + 3 in older adults with newly diagnosed high-risk and/or secondary AML. Blood Adv. 2022;6(17):4989-4993
Figures
Erratum for
-
Transplant outcomes after CPX-351 vs 7 + 3 in older adults with newly diagnosed high-risk and/or secondary AML.Blood Adv. 2022 Sep 13;6(17):4989-4993. doi: 10.1182/bloodadvances.2021006468. Blood Adv. 2022. PMID: 35443022 Free PMC article. No abstract available.
